Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?

General Info

Geography

Angola (AGO)

Benin (BEN)

Botswana (BWA)

Burkina Faso (BFA)

Burundi (BDI)

Cameroon (CMR)

Central African Republic (CAF)

Chad (TCD)

Congo (COG)

Côte d'Ivoire (CIV)

Democratic Republic of the Congo (COD)

Djibouti (DJI)

Equatorial Guinea (GNQ)

Eritrea (ERI)

Ethiopia (ETH)

Gabon (GAB)

Gambia (GMB)

Ghana (GHA)

Guinea (GIN)

Guinea-Bissau (GNB)

Kenya (KEN)

Lesotho (LSO)

Liberia (LBR)

Malawi (MWI)

Mali (MLI)

Mauritania (MRT)

Mozambique (MOZ)

Namibia (NAM)

Niger (NER)

Nigeria (NGA)

Rwanda (RWA)

Senegal (SEN)

Sierra Leone (SLE)

Somalia (SOM)

South Africa (ZAF)

Sudan (SDN)

Eswatini (SWZ)

Togo (TGO)

Uganda (UGA)

United Republic of Tanzania (TZA)

Zambia (ZMB)

View all

Coverage type

Global

Time period covered

January, 2013 - December, 2013

Data type

Scientific literature

Keywords

Antiretroviral therapy, DALYs, HIV and AIDS, HIV transmission, Health care costs, Health care economics, Health care expenditures, Risk factors

Citation

Authors

Verguet S, Stalcup M, Walsh JA

Journal

Sex Transm Infect

Pages

628-34

Publication year

2013

Suggested citation

Verguet S, Stalcup M, Walsh JA. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?. Sex Transm Infect. 2013; 89(8): 628-34.